nLIGHT, Inc. Common Stock
LASR
$74.12
-6.36%
nLIGHT, Inc. is a technology company that designs, manufactures, and sells high-power semiconductor lasers and fiber lasers, primarily for integration into systems serving the aerospace and defense, industrial, and microfabrication markets. The company operates as a specialized supplier within the optoelectronics and semiconductor laser industry, focusing on high-performance applications. The current investor narrative is heavily driven by its association with the broader optoelectronics and AI infrastructure rally, as highlighted by a significant sector surge in early March 2026 linked to Nvidia's optical technology partnerships, positioning nLIGHT as a potential beneficiary in the advanced photonics supply chain.…
LASR
nLIGHT, Inc. Common Stock
$74.12
Investment Opinion: Should I buy LASR Today?
Rating: Hold. The core thesis is that LASR is a compelling turnaround story with spectacular fundamental improvement, but its extreme valuation and technical extension after a 452% rally price in near-perfect execution, leaving asymmetric risk to the downside.
Supporting evidence includes the dramatic Q4 gross margin recovery to 30.74%, 71% YoY revenue growth, strong liquidity (current ratio 3.79), and positive free cash flow generation of $12.3M TTM. However, these positives are counterbalanced by a forward P/E of 116.27x, a still-negative ROE of -10.35%, and a stock trading at 90% of its 52-week high. Analyst consensus is bullish, but the limited coverage and wide estimate ranges introduce uncertainty.
The two biggest risks that could invalidate a Hold thesis are 1) a failure to achieve the forward EPS of $1.80, exposing the extreme valuation, and 2) a breakdown in technical support around $70, signaling the end of the momentum rally. This Hold would upgrade to a Buy if the stock experiences a significant correction (e.g., 20-30%) that improves the risk/reward profile, or if the company reports consecutive profitable quarters. It would downgrade to a Sell if revenue growth decelerates sharply below 30% or if gross margins retreat from the 30%+ level. Relative to its own history and the implied growth required, the stock is overvalued in the near term, though fairly valued for a long-term investor who believes in the sustainability of its turnaround.
Sign up to view all
LASR 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on nLIGHT, Inc. Common Stock's 12-month outlook, with a consensus price target around $96.36 and implied upside of +30.0% versus the current price.
Average Target
$96.36
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$59 - $96
Analyst target range
Analyst coverage appears limited, with data indicating only one analyst providing estimates for revenue and EPS, though institutional ratings show activity from several firms. The consensus sentiment is overwhelmingly bullish, with recent actions from Needham, Cantor Fitzgerald, Roth Capital, and Stifel all being Buy or Overweight ratings, and no downgrades visible in the provided data. The average revenue estimate for the forward period is $584 million, with a range from $563.5 million to $615.0 million, while the average EPS estimate is $1.80, ranging from $1.72 to $1.92. The wide range between the low and high revenue and EPS estimates signals a degree of uncertainty or variability in the growth outlook, which is typical for a company in a rapid transformation phase. The consistent pattern of reiterated Buy ratings following earnings reports suggests analysts have conviction in the ongoing turnaround story. The limited number of formal estimates, however, implies this is still a smaller-cap stock with niche institutional interest, which can contribute to the high volatility (beta of 2.335) observed in the price action.
Bulls vs Bears: LASR Investment Factors
The bullish case, driven by explosive 71% revenue growth, a dramatic gross margin recovery from 2% to 31%, and strong analyst sentiment, currently holds stronger evidence due to the concrete, improving fundamentals. However, the bearish concerns regarding extreme valuation (116x forward P/E), lack of current profitability, and an extended stock price after a 452% rally are substantial. The single most important tension in the investment debate is whether the company can bridge the massive valuation gap by achieving and sustaining the high-profit margins and growth rates implied by its forward multiples, or if the current price reflects peak optimism for a still-unprofitable business. The resolution of this profitability question will determine the stock's direction.
Bullish
- Explosive Revenue Growth: Q4 2025 revenue grew 71.35% year-over-year to $81.185 million, accelerating from a sequential trend that began at $51.668 million in Q1 2025. This demonstrates robust demand, particularly in the high-margin Aerospace & Defense segment, which generated $56.3 million in the quarter.
- Dramatic Gross Margin Recovery: Gross margin surged to 30.74% in Q4 2025 from a severely depressed 2.39% in Q4 2024. This 28.35 percentage point improvement signals a powerful turnaround in operational efficiency, pricing power, and product mix, directly impacting the path to profitability.
- Strong Balance Sheet & Cash Flow: The company has a robust current ratio of 3.79 and minimal debt with a D/E ratio of 0.16. Critically, it generated $15.93 million in free cash flow in Q4 2025 and $12.3 million TTM, showing an improving ability to fund its growth internally.
- Overwhelmingly Bullish Analyst Sentiment: Recent institutional actions from Needham, Cantor Fitzgerald, Roth Capital, and Stifel are all Buy or Overweight ratings. The average forward revenue estimate is $584 million, implying significant growth from current run-rate levels.
Bearish
- Extreme Valuation & Profitability Gap: The stock trades at a forward P/E of 116.27x based on estimated EPS of $1.80, while trailing P/E is -81.41x due to net losses. This massive gap requires flawless execution of future earnings growth to justify, leaving no margin for error.
- Still Unprofitable with Negative ROE: The company reported a Q4 2025 net loss of $4.909 million and has a trailing Return on Equity of -10.35%. Despite dramatic improvement from a $24.962 million loss a year prior, profitability is not yet achieved, creating fundamental risk.
- Extended Price & Extreme Volatility: The stock is up 452% over one year and trades at 90% of its 52-week high ($86.95), suggesting it is extended and vulnerable to profit-taking. Its beta of 2.335 means it is 133% more volatile than the market, amplifying downside risk.
- Limited Analyst Coverage & High Uncertainty: Formal estimates come from only one analyst, and the wide range between low ($563.5M) and high ($615.0M) revenue estimates signals significant uncertainty in the growth outlook. This niche coverage can exacerbate price swings.
LASR Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 452.36% gain over the past year. As of the latest close at $78.545, the price is trading near the top of its 52-week range, approximately 90% of the way from its low of $13.45 to its high of $86.95, indicating strong momentum but also suggesting the stock is extended and may be susceptible to profit-taking. Recent momentum remains robust but shows signs of volatility; the stock is up 40.23% over three months and 9.12% over one month, though the 1-month gain is notably lower than the longer-term rates, hinting at a potential consolidation or deceleration within the broader uptrend. Key technical levels are clear, with immediate resistance at the 52-week high of $86.95 and support at the 52-week low of $13.45, though more relevant near-term support may be found around the $70 level based on recent price action. A breakout above $86.95 would signal a continuation of the explosive rally, while a breakdown below $70 could indicate a deeper correction. The stock exhibits extreme volatility, with a beta of 2.335, meaning it is approximately 133% more volatile than the broader market (SPY), which necessitates careful risk management and position sizing for investors.
Beta
2.33
2.33x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$15-$87
Price range past year
Annual Return
+376.0%
Cumulative gain past year
| Period | LASR Return | S&P 500 |
|---|---|---|
| 1m | +14.1% | +6.3% |
| 3m | +31.9% | +10.3% |
| 6m | +110.4% | +10.7% |
| 1y | +376.0% | +28.2% |
| ytd | +93.2% | +10.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LASR Fundamental Analysis
Revenue is on a strong growth trajectory, with Q4 2025 revenue reaching $81.185 million, representing a substantial 71.35% year-over-year increase. This acceleration is clear when examining the sequential quarterly trend from Q1 2025 ($51.668M) to Q4 2025, indicating robust demand, particularly in its core Aerospace & Defense segment, which contributed $56.3 million in the latest period. The company remains unprofitable on a net income basis, reporting a Q4 2025 net loss of $4.909 million, but this marks a significant improvement from a $24.962 million loss in Q4 2024. Gross margin has recovered impressively to 30.74% in Q4 2025 from a severely depressed 2.39% a year ago, signaling a dramatic turnaround in operational efficiency and pricing power. The balance sheet is solid, with a strong current ratio of 3.79 and a very low debt-to-equity ratio of 0.16, indicating minimal financial leverage and ample liquidity. The company generated positive free cash flow of $12.298 million on a trailing twelve-month basis and $15.93 million in Q4 2025 alone, demonstrating an improving ability to fund operations internally. However, return on equity remains deeply negative at -10.35%, reflecting the cumulative net losses, though the trend is improving sharply from the -11.53% ROE seen in the prior year's quarter.
Quarterly Revenue
$81185000.0B
2025-12
Revenue YoY Growth
+0.71%
YoY Comparison
Gross Margin
+0.30%
Latest Quarter
Free Cash Flow
$12298000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LASR Overvalued?
Given the negative trailing net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 7.31x and an Enterprise Value-to-Sales (EV/Sales) of 13.85x. The forward PE ratio of 116.27x, based on estimated EPS of $1.80, indicates the market is pricing in a significant future earnings recovery, creating a large gap with the negative trailing PE of -81.41x. Comparable industry average data is not provided in the valuation dataset, so a direct peer comparison cannot be quantified. However, a PS ratio of 7.31x for a company showing 71% YoY revenue growth and rapidly improving margins could be considered reasonable in the high-growth semiconductor/laser sector, especially if the growth is sustainable. The stock's current valuation is near the top of its own historical range; its PS ratio of 7.31x is substantially lower than the 23.53x recorded at the end of Q4 2025, but this historical spike was likely an anomaly. The current multiple is well above levels seen in early 2025 (e.g., 7.38x in Q1 2025), suggesting the market has already priced in much of the recent operational improvement and growth acceleration.
PE
-81.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -97x~-5x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-92.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's transition from deep losses to profitability. While net losses improved from -$24.96M to -$4.91M YoY in Q4, the trailing ROE remains negative at -10.35%, and the forward P/E of 116x is entirely dependent on achieving estimated EPS of $1.80. Revenue, though growing rapidly at 71% YoY, remains concentrated in the Aerospace & Defense segment ($56.3M of $81.2M in Q4), creating customer and end-market concentration risk. The valuation is highly sensitive to any deceleration in growth or margin expansion.
Market & Competitive Risks are pronounced due to the stock's extreme valuation and volatility. Trading at a PS ratio of 7.31x and EV/Sales of 13.85x, LASR is vulnerable to valuation compression if growth stock multiples contract or if sector rotation away from speculative AI/optoelectronics plays occurs, as hinted by the March 2026 news-driven rally. The beta of 2.335 indicates high correlation to market sentiment swings, magnifying macro risks. As a smaller player in the semiconductor laser space, it faces competitive disruption from larger, more diversified rivals.
Worst-Case Scenario involves a simultaneous failure to achieve profitability targets and a broader market downturn for high-multiple growth stocks. This could trigger analyst downgrades, a collapse in the speculative AI-narrative premium, and a rush for exits. The realistic downside could see the stock re-test its 52-week low of $13.45, representing a potential loss of approximately -83% from the current price of $78.545. A more probable severe correction, aligning with a breakdown below key technical support near $70 and a return to a more normalized PS ratio, could see a -35% to -50% drawdown, consistent with its historical max drawdown of -24.74% observed in recent volatile trading.